Fatima A Hamid obtained her B.s in pharmacy from University of Khartoum, Sudan, and M.s in toxicology from Università degli Studi di Milano in Italy in 2019. Her research focuses on using nanoparticles-based carriers and novel adjuvants targeting Toll-like receptor (TLRs) to enhance the efficacy of anti-opioids conjugate vaccines. Moreover, dissecting the molecular and cellular mechanisms associated with this enhancement to provide a blueprint for rational vaccine design. In her spare time, Fatima loves to travel to new places, and try new food.